ACT Genomics Co.
Latest round
- Series B
Last raised
- May 2016
Total raised
- $13M
Investors
- 6
About ACT Genomics Co.
, LTD., LTD. focuses on providing genomic testing services to optimize cancer treatment.00 mn.ACT Genomics specializes in precision medicine via advanced genomic testing solutions aimed at improving cancer care. The company offers various genomic assays, including comprehensive and targeted panels, to identify biomarkers and genomic alterations linked to different cancers. These tests enable personalized treatment strategies by helping oncologists align patients with specific therapies and clinical trials based on their unique genetic profiles. With a client base exceeding 200 hospitals and clinics and over 700 physicians, ACT Genomics collaborates with more than 20 biopharma companies and research institutes for clinical diagnostics and research.ACT Genomics generates revenue through B2B transactions with healthcare professionals and institutions by providing genomic testing services and consulting for cancer management. Collaborating with healthcare providers allows the company to deliver actionable insights from genomic profiling, which assists in treatment selection and patient management. Revenue streams consist of service fees for genomic tests, and potential subscription models for ongoing support and resources offered to healthcare practitioners.The recent acquisition by Prenetics Global Limited is anticipated to close on or around December 30, 2022, allowing ACT Genomics to leverage genetic information across a patient's cancer journey. As part of its growth strategy, ACT Genomics may explore new products and services tailored to evolving market needs, although specific upcoming releases have not been publicly detailed. The planned integration with Prenetics aims to enhance the application of genetic data in oncology, potentially leading to further market expansion.
Who invested in ACT Genomics Co.
6 investors across 1 round
See all investors in ACT Genomics Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
May 6, 2016
Amount
$13M
Investors
Questions about ACT Genomics Co.
Who invested in ACT Genomics Co.?
ACT Genomics Co. has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ACT Genomics Co. raised?
ACT Genomics Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ACT Genomics Co. last raise money?
ACT Genomics Co.'s most recent round on record is a Series B, in May 2016.
What does ACT Genomics Co. do?
ACT Genomics Co. is a biotechnology company.
Where is ACT Genomics Co. headquartered?
ACT Genomics Co. is headquartered in Taipei, Taiwan - China.
Which VCs invest in companies like ACT Genomics Co.?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ACT Genomics Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like ACT Genomics Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.